Skip to content

Effect of goal-directed fluid therapy on endothelial glycocalyx function in cesarean delivery in twin pregnancies

Effect of goal-directed fluid therapy on endothelial glycocalyx function in cesarean delivery in twin pregnancies

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066384
Enrollment
Unknown
Registered
2022-12-03
Start date
2022-12-03
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volume management of pregnant women with twin pregnancy

Interventions

Group H(11%=SVV=15%):N/A
Group L(6%=SVV=10%):N/A

Sponsors

Nanjing Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists score (American Society of Anesthesiologists,ASA) is I~II, elective twin pregnancy cesarean section, age 18 to 45 years old.

Exclusion criteria

Exclusion criteria: 1, twin pregnant women with vaginal trial delivery, 2, pregnant women with cardiopulmonary, hepatorenal insufficiency, 3, pregnant women with severe infection, dehydration, electrolyte disturbance and shock, 4, parturients with abnormal blood coagulation and moderate and severe anemia, 5. History of hypersensitivity to hydroxyethyl starch HES (130ram0.4) and sodium lactate Ringer injection (SodiumLactateRinger'sInjection,LR). 6. application of drugs that affect cardiac function, such as ß-receptor antagonists, calcium channel blockers, digitalis, etc.; 7, severe brain injury, confusion of consciousness, respiratory inhibition; 8, absolute contraindications of intraspinal anesthesia; 9. Parturients who have participated in other clinical trials and are participating in other clinical trials within 3 months before joining the group. 10. According to the doctor in charge of the trial, the implementation of the trial may increase the risk of the subjects, or may not be able to obtain sufficient trial data.

Design outcomes

Primary

MeasureTime frame
diamine oxidase, DAO;N terminal pro B type natriuretic peptide, NT-proBNP;

Secondary

MeasureTime frame
Postoperative quality of recovery score, QoR-40;Neonatal outcome;

Countries

China

Contacts

Public ContactHuiying Zhang

Nanjing Maternal and Child Health Hospital

279763402@qq.com13851690367

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026